Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03503929
Other study ID # LAP-PRO-001
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date June 21, 2019
Est. completion date October 30, 2024

Study information

Verified date March 2023
Source Mariner Endosurgery
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

LaparoGuard is intended as an adjunctive safety system for laparoscopic surgery. The system allows surgeons to virtually annotate a safe anatomical volume inside the body cavity of the patient during a laparoscopic surgery. The surgeon then receives notification throughout the procedure whenever a tracked rigid instrument has exited that volume. This open label, prospective, feasibility, single site, multi-investigator trial will evaluate the feasibility and usability of the LaparoGuard system during laparoscopic surgical procedures.


Description:

PHASE 1) LaparoGuard will be used as an adjunctive tool for maintaining safety during procedures performed by expert surgeons. The pre-operative instructions for use will be evaluated along with ease of procedural setup, as reported by pre-operative nurses. The intraoperative instructions for use will be evaluated along with system usability, as reported by the expert surgeons. The perceived clinical utility will be judged by expert surgeons. Postoperatively, the system data will be reviewed. This phase will include 4-6 subjects. PHASE 2) Novice surgeons will conduct procedures alongside expert surgeons. Expert surgeons will establish the safe zone. LaparoGuard will record all deviations, speed and smoothness of tip movements. The training utility of LaparoGuard will be assessed by both the expert and novice surgeons. This phase will include 4-6 subjects.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 60
Est. completion date October 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing routine laparoscopic procedures. Examples include (non-exhaustive): operative laparoscopy, appendectomy, cholecystectomy, colon resection, inguinal or diaphragmatic hernia repairs. - Ability to read and understand English - Consent to use of the LaparoGuard system in their procedure (18 yrs or older) Exclusion Criteria: - Unwilling to sign informed consent - Simple diagnostic laparoscopy (can be included if conversion to operative laparoscopy) - Surgeries which require conversion to laparotomy for patient safety reasons

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LaparoGuard System
Adjunctive safety system for laparoscopic surgery

Locations

Country Name City State
Canada Hamilton General Hospital Hamilton Ontario

Sponsors (3)

Lead Sponsor Collaborator
Mariner Endosurgery Federal Economic Development Agency for Southern Ontario (FedDev Ontario), Hamilton Health Sciences Corporation

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Procedural Success For each surgical procedure conducted, the case will be defined as a technical success if: the surgical team is able to complete the procedure without needing to turn off the LaparoGuard system. Failure will be if the operator deems it necessary to stop utilizing the LaparoGuard system and resort to the standard (non-annotated) endoscopic camera feed. Potential reasons for doing so may be device reporting errors, such as the LaparoGuard system consistently incorrectly reporting that a surgical tool has exited the safe zone.
In emergency situations, such as changes in medical condition unrelated to use of the LaparoGuard system, the operator may also deem it necessary to resort to the standard-of-care; however, these situations will not be judged as failures and the case data will be utilized for study purposes up until that point.
Intraoperative
Secondary Pre-operative LaparoGuard system setup time The amount of time taken to setup the LaparoGuard system by the surgical nurses will be recorded Baseline
Secondary Usability reported pre-operatively by nurses Following setup of the LaparoGuard system preoperatively, but prior to bringing the patient into the surgical suite, study staff will conduct a short interview with the surgical nurses to evaluate their comfort and ease with the system setup procedures. If any use errors or confusion were observed by the study staff, these shall be discussed in depth. Comments reported by the nurses on difficulties encountered and potential simplifications to the procedures will be recorded. Baseline
Secondary Safe zone deviations The total number of safe zone deviations as well the total time each instrument was outside the safe zone will be tracked and evaluated. Intraoperative
Secondary Usability reported post-operatively by surgical team Following completion of each surgical procedure, study staff will conduct a short interview with the surgical team to evaluate the ability of the team to interpret the LaparoGuard output, the safe zone and respond to any information provided by system. Intraoperative
Secondary Clinical utility reported by expert surgeons Following the completion of all 10 cases, study staff will conduct interviews with the expert surgeons to evaluate their perceived clinical utility of the LaparoGuard system. A qualitative discussion will held around the particular clinical situations in which LaparoGuard may be most useful. Study staff will also record any potential insights by the surgeons on future features which may be incorporated to improve the clinical utility of LaparoGuard. 2 months
Secondary Training utility reported by novice and expert surgeons Following the completion of all 10 cases, study staff will conduct interviews with the expert and novice surgeons to evaluate their perceived training utility of the LaparoGuard system. Quantitative rating scales will be used and qualitative discussion will held around the particular training situations in which LaparoGuard may be most useful. Study staff will also record any potential insights by the expert or novice surgeons on future features which may be incorporated to improve the training utility of LaparoGuard. 2 months
See also
  Status Clinical Trial Phase
Completed NCT03704259 - Nano-Ceramic Coating for Laparoscope Lens
Completed NCT02320578 - 2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial N/A
Completed NCT02756052 - Enhancing Laparoscopic Skill Acquisition and Retention With Transcranial Direct-current Stimulation N/A
Completed NCT02417857 - Comparison of Single İncision Laparoscopic Cholecystectomy Versus Laparoscopic Cholecystectomy N/A
Completed NCT00433316 - Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy Phase 3
Recruiting NCT00280553 - A Pilot Study of Bupivacaine Infusion in Abdominal Surgery Phase 2